Anemia, bilirubin, and cardiovascular autonomic neuropathy in patients with type 2 diabetes

Medicine (Baltimore). 2017 Apr;96(15):e6586. doi: 10.1097/MD.0000000000006586.

Abstract

To investigate the relationship among anemia, physiological serum bilirubin levels, and cardiovascular autonomic neuropathy (CAN) in subjects with type 2 diabetes. In total, 2230 subjects with type 2 diabetes were evaluated in this cross-sectional study. CAN was diagnosed with a cardiovascular reflex test. The prevalence of anemia was greater in subjects with CAN. In multivariable analysis, the relationship between anemia and CAN remained statistically significant after adjusting for the risk factors (odds ratio [OR] 1.39; 95% confidence interval [CI] 1.07-1.80, P = .015). Additional adjustment for serum bilirubin concentrations abolished this relationship (OR 1.20, 95% CI 0.91-1.58, P = .189). Anemia is positively associated with the prevalence of CAN in subjects with type 2 diabetes. In addition, our results suggest that the putative increased CAN risk associated with anemia might be mediated by a correlated decrease in serum bilirubin levels.

MeSH terms

  • Anemia / blood
  • Anemia / epidemiology*
  • Anemia / etiology
  • Autonomic Nervous System Diseases / blood
  • Autonomic Nervous System Diseases / epidemiology*
  • Autonomic Nervous System Diseases / etiology
  • Bilirubin / blood*
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetic Cardiomyopathies / blood
  • Diabetic Cardiomyopathies / epidemiology
  • Diabetic Cardiomyopathies / etiology
  • Diabetic Neuropathies / blood
  • Diabetic Neuropathies / epidemiology*
  • Diabetic Neuropathies / etiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Prevalence
  • Risk Factors

Substances

  • Bilirubin